Skip to main content

Table 1 In vivo effective orifice area values (cm2) corresponding to each valve

From: Impact of prosthesis–patient mismatch on short-term outcomes after aortic valve replacement: a retrospective analysis in East China

Valve prosthesis No. of patients n(%) 17 mm
1.8%
19 mm
8.7%
21 mm
27.7%
23 mm
30.0%
25 mm
22.6%
27 mm
7.0%
29 mm
1.5%
31 mm
0.6%
ref
Mechanical
 CarboMedics Orbis Universal Valve 517(59.5) 1 1.2 1.5 1.7 2 2.5 2.6 2.7 [19]
 ATS Open Pivot 500FA (size, mm) 10(1.2) 0.6 (16) 1 1.6 1.8 2.2 2.5 3.1   [15]
 ATS Open Pivot AP360 (size, mm) 2(0.2) 1.2 (16) 1.5 (18) 1.7 (20) 2.1 (22) 2.5 (24) 3.1 (26)    [20]
 St. Jude Regent Valve 40(4.6) 1.2 1.6 2 2.2 2.5 3.6 4.4   [21]
 St. Jude Master Series 90(10.4) 1 1.2 1.5 2.0 2.6 3.1    [22]
Bioprosthesis
 Hancock II Procine Bioprosthesis 120(13.8)    1.2 1.3 1.5 1.6 1.6   [19]
 Mosaic Procine Bioprosthetic Valve 4(0.5)   1.1 1.2 1.4 1.7 1.8 2   [23]
 St. Jude Biocor Stented Tissue Valve 47(5.4)    1.3 1.6 1.8 2    [24]
 Carpentier-Ed PERIMOUNT 32(3.7)   1.1 1.3 1.5 1.8 2.1 2.2   [19]
 Carpentier-Ed PERIMOUNT MAGNA 7(0.8)   1.3 1.7 2.1 2.3     [24]
PPM rate of each valve sizes   81.2% 52.6% 19.1% 10.7% 4.6% 3.3% 0% 0%  
  1. PPM prosthesis patient mismatch, ref reference